Wednesday, May 24, 2017

HealthCare Practice Term Loans - Call 904-551-6090: Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore. Source link Read more...

No comments: